English 
Italian 
Product description
Active substance:
Risendronic Acid
Form:
Cps
Dosage/Packaging:
35mg
4 Cps 35mg
Shelf life:
36 months
Indications:
Treatment of postmenopausal osteoporosis to reduce the risk of vertebral fractures. Treatment of postmenopausal osteoporosis manifested to reduce the risk of hip fractures. Treatment of osteoporosis in men at high risk of fractures.